[HTML][HTML] Final version of 2009 AJCC melanoma staging and classification
…, AM Eggermont, KT Flaherty, PA Gimotty… - Journal of clinical …, 2009 - ncbi.nlm.nih.gov
Purpose To revise the staging system for cutaneous melanoma on the basis of data from an
expanded American Joint Committee on Cancer (AJCC) Melanoma Staging Database. …
expanded American Joint Committee on Cancer (AJCC) Melanoma Staging Database. …
[HTML][HTML] Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
…, D Katsaros, PA Gimotty… - New England journal …, 2003 - Mass Medical Soc
Background Although tumor-infiltrating T cells have been documented in ovarian carcinoma,
a clear association with clinical outcome has not been established. Methods We performed …
a clear association with clinical outcome has not been established. Methods We performed …
Melanoma staging: evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
…, C Garbe, JM Gardner, PA Gimotty… - CA: a cancer journal …, 2017 - Wiley Online Library
… Gardner, MHA, BS (Manager, Clinical Protocol Administration, The University of Texas MD
Anderson Cancer Center); Phyllis A. Gimotty, PhD (Professor of Biostatistics, University of …
Anderson Cancer Center); Phyllis A. Gimotty, PhD (Professor of Biostatistics, University of …
[PDF][PDF] Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K
…, AK Cipolla, B Wubbenhorst, X Xu, PA Gimotty… - Cancer cell, 2010 - cell.com
BRAF is an attractive target for melanoma drug development. However, resistance to BRAF
inhibitors is a significant clinical challenge. We describe a model of resistance to BRAF …
inhibitors is a significant clinical challenge. We describe a model of resistance to BRAF …
microRNAs exhibit high frequency genomic alterations in human cancer
…, A Hatzigeorgiou, PA Gimotty… - Proceedings of the …, 2006 - National Acad Sciences
MicroRNAs (miRNAs) are endogenous noncoding RNAs, which negatively regulate gene
expression. To determine genomewide miRNA DNA copy number abnormalities in cancer, …
expression. To determine genomewide miRNA DNA copy number abnormalities in cancer, …
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
…, K Balint, A Barchetti, LP Wang, PA Gimotty… - Nature, 2011 - nature.com
Although immune mechanisms can suppress tumour growth 1 , 2 , tumours establish potent,
overlapping mechanisms that mediate immune evasion 3 , 4 , 5 , 6 . Emerging evidence …
overlapping mechanisms that mediate immune evasion 3 , 4 , 5 , 6 . Emerging evidence …
The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis
…, A Li, G Huang, AJ Klein-Szanto, PA Gimotty… - Nature cell …, 2008 - nature.com
MicroRNAs (miRNAs) are single-stranded, noncoding RNAs that are important in many
biological processes 1 , 2 . Although the oncogenic and tumour-suppressive functions of several …
biological processes 1 , 2 . Although the oncogenic and tumour-suppressive functions of several …
[HTML][HTML] A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth
…, PA Brafford, A Vultur, D Basu, P Gimotty… - Cell, 2010 - cell.com
Melanomas are highly heterogeneous tumors, but the biological significance of their
different subpopulations is not clear. Using the H3K4 demethylase JARID1B (KDM5B/PLU-1/RBP2-…
different subpopulations is not clear. Using the H3K4 demethylase JARID1B (KDM5B/PLU-1/RBP2-…
Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice
…, L Maiorino, C Bautista, EM Carmona, PA Gimotty… - Science, 2018 - science.org
INTRODUCTION Most cancer patients die from cancer that recurs after spreading to a different
tissue, rather than from their original tumor. After successful treatment of the original tumor…
tissue, rather than from their original tumor. After successful treatment of the original tumor…
Organoid profiling identifies common responders to chemotherapy in pancreatic cancer
…, W Nealon, JD Sullivan, JM Winter, PA Gimotty… - Cancer discovery, 2018 - AACR
Pancreatic cancer is the most lethal common solid malignancy. Systemic therapies are often
ineffective, and predictive biomarkers to guide treatment are urgently needed. We …
ineffective, and predictive biomarkers to guide treatment are urgently needed. We …